Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 9,281 filings

Top spenders & firms Spend by issue

Clear
Q1
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ for MIMEDX
1st Quarter (Jan 1 - Mar 31) 2026 · Georgia · House · Senate · $20,000.00 income
Medicare/Medicaid
View →
Q1
THE SMITH-FREE GROUP, LLC for HCA
1st Quarter (Jan 1 - Mar 31) 2026 · Tennessee · House · Senate · $70,000.00 income
Health Issues, Medicare/Medicaid
View →
Q1
THE MCMANUS GROUP for ROCHE DIAGNOSTICS
1st Quarter (Jan 1 - Mar 31) 2026 · Indiana · House · Senate · $40,000.00 income
Medicare/Medicaid, Trade (domestic/foreign)
View →
Q1
DANA-FARBER CANCER INSTITUTE for DANA-FARBER CANCER INSTITUTE
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate
Budget/Appropriations, Health Issues, Medicare/Medicaid, Medical/Disease Research/Clinical Labs
View →
Q1
HEALTHCARE ASSOCIATION OF NYS for HEALTHCARE ASSOCIATION OF NYS
1st Quarter (Jan 1 - Mar 31) 2026 · New York · House · Senate
Medicare/Medicaid
View →
Q1
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ for HONORBRIDGE
1st Quarter (Jan 1 - Mar 31) 2026 · North Carolina · House · Senate · $10,000.00 income
Health Issues, Medicare/Medicaid
View →
Q1
BRISTOL-MYERS SQUIBB COMPANY for BRISTOL-MYERS SQUIBB COMPANY
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Copyright/Patent/Trademark
View →
Q1
TARPLIN, DOWNS & YOUNG, LLC for BIOTECHNOLOGY INDUSTRY ORGANIZATION
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $80,000.00 income
Budget/Appropriations, Medicare/Medicaid, Health Issues, Taxation/Internal Revenue Code
View →
Q1
VALCOUR LLC for COMMUNITY OPTIONS INC
1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $50,000.00 income
Medicare/Medicaid
View →
Q1
THE MCMANUS GROUP for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues
View →
Q1
SMITHBUCKLIN CORPORATION for ASTCT
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $70,000.00 income
Medical/Disease Research/Clinical Labs, Health Issues, Medicare/Medicaid
View →
Q1
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ for HATTIESBURG CLINIC
1st Quarter (Jan 1 - Mar 31) 2026 · Mississippi · House · Senate
Medicare/Medicaid
View →
Q1
THE MCMANUS GROUP for INFUSION PROVIDERS ALLIANCE
1st Quarter (Jan 1 - Mar 31) 2026 · Delaware · House · Senate · $90,000.00 income
Medicare/Medicaid, Health Issues
View →
Q1
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ for FORREST GENERAL HOSPITAL
1st Quarter (Jan 1 - Mar 31) 2026 · Mississippi · House · Senate · $20,000.00 income
Medicare/Medicaid
View →
Q1
JEFFREY J. KIMBELL & ASSOCIATES, INC. for RECOR MEDICAL
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $20,000.00 income
Health Issues, Medicare/Medicaid
View →
Q1
JEFFREY J. KIMBELL & ASSOCIATES, INC. for NEUSPERA MEDICAL
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $10,000.00 income
Medicare/Medicaid
View →
Q1
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ for CHARTSPAN
1st Quarter (Jan 1 - Mar 31) 2026 · South Carolina · House · Senate
Medicare/Medicaid
View →
Q1
W STRATEGIES, LLC for SANOFI U.S. SERVICES, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · $50,000.00 income
Medicare/Medicaid
View →
Q1
W STRATEGIES, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · $60,000.00 income
Medicare/Medicaid
View →
Q1
THE MCMANUS GROUP for AMBULATORY SURGERY CENTER ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues
View →
Q1
TARPLIN, DOWNS & YOUNG, LLC for ASTRAZENECA
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $80,000.00 income
Budget/Appropriations, Medicare/Medicaid, Health Issues
View →
Q1
W STRATEGIES, LLC for OTSUKA AMERICA PHARMACEUTICAL, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Maryland · House · $50,000.00 income
Medicare/Medicaid
View →
Q1
BALLARD PARTNERS for WALGREEN CO.
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House
Medicare/Medicaid
View →
Q1
W STRATEGIES, LLC for GLAXOSMITHKLINE
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · $40,000.00 income
Medicare/Medicaid
View →
Q1
W STRATEGIES, LLC for GILEAD SCIENCES, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · $60,000.00 income
Medicare/Medicaid
View →
Previous Page 26 of 372 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem